Crain’s Chicago Business, a highly regarded publication known for its in-depth reporting on business and innovation, features Prenosis CEO Bobby Reddy, Jr. in an article exploring Chicago’s emergence as a biotechnology hub. Reddy discusses Prenosis’ pivotal role...
Diagnostics firm adds investor to bring funding over $20M–MedCity
MedCity News, a trusted source for healthcare innovation and investment news, highlights Prenosis’ recent investment from PACE Healthcare Capital, advancing its mission to revolutionize sepsis care with AI-driven diagnostics and precision medicine solutions....
Prenosis Nabs Up to $4.3 Million From US DoD to Develop Early Sepsis POC Test–360Dx
360Dx, a leading source for clinical diagnostics news, highlights Prenosis’ milestone $4.3 million award from the US Department of Defense to advance sepsis detection technology for warfighters, reinforcing the transformative impact of its innovations in acute...
Prenosis, Roche Partner on Sepsis Detection–360Dx
360Dx, a leading publication covering innovations in clinical diagnostics, reports on Prenosis’ expanding collaboration with Roche Diagnostics, a significant step toward advancing sepsis detection and improving patient outcomes. The partnership aims to leverage...
Prenosis Aggregating Patient Biomarker, Clinical Data to Build a Better Sepsis Diagnostic–360Dx
360Dx, a leading publication focused on the clinical diagnostics industry, profiled Prenosis in its latest feature. The article explores how Prenosis is advancing precision medicine through its Sepsis ImmunoScore™, and its groundbreaking Immunix™ platform. 360Dx...
New Test Leverages Machine Learning to Diagnose and Predict Sepsis–MD+DI
MD+DI profiles Prenosis for its groundbreaking work in sepsis diagnostics. In this article CEO Bobby Reddy, Jr. highlights the immense global burden of sepsis, a condition responsible for more deaths worldwide than all cancers combined. Prenosis’ Immunix™ platform and...